Covidien Parietex Composite Mesh Lawsuit Claims Hernia Patch Dangerously Defective

|

According to allegations raised in a hernia mesh lawsuit recently filed against Covidien and Medtronic, Inc., the Parietex Composite Mesh is defectively designed and a danger to patients, increasing the risk of painful complications following hernia repair. 

Following the failure of the Covidien Parietex mesh, resulting in the need for revision surgery, Louisiana filed a product liability complaint (PDF) against the medical device manufacturers on January 12, in the U.S. District Court for the Western District of Louisiana.

Lacassin indicates that she underwent surgery for hernia repair in November 2011, at which time doctors implanted the Covidien Parietex Composite Mesh.

Is there a hernia mesh lawsuit? Find out if you qualify for a hernia mesh lawsuit settlement payout.
Is there a hernia mesh lawsuit? Find out if you qualify for a hernia mesh lawsuit settlement payout.

“As a result of the implantation of the unreasonably dangerous and defective Parietex Composite Mesh, Plaintiff suffered injuries including, but not limited to, scarring, pain, recurrence, and additional surgery,” the lawsuit states.

The complaint indicates that numerous reports of problems with Parietex Composite Mesh have been submitted to the FDA, maintaining that Covidien and Medtronic misrepresented the safety and effectiveness of the hernia patch to the public and medical community.

“The absorbable collagen barrier on the visceral side of Parietex Composite Mesh fails to protect the body from the hydrophilic three-dimensional polyester textile on the parietal side because the absorbable collagen barrier breaks down after coming in contact with moisture and tears easily during handling. The composition of polyester is also weak and Parietex Composite Mesh is known to unravel causing the polyester fiber to detach and travel to other parts of the body inciting an inflammatory response,” Lacassin indicates in the lawsuit. “Parietex Composite Mesh further contracts over time causing tension to increase where secured by tacks and sutures resulting in tearing.”

Lacassin presents claims for construction or composition defect, design defect, inadequate warning, breach of warranty, negligence, and redhibition. The case joins a growing number of similar cases filed over design problems with different hernia mesh products sold in recent years. In addition to cases for Covidien Parietex Mesh, similar allegation have been raised in Ethicon Physiomesh lawsuits, Atrium C-Qur lawsuits, Bard Ventralex lawsuits and other claims.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.

Image Credit: |test caption



1 Comments


fred
I have been suffering with inflammation, swelling and acute pain since the hernia operation. The operation took place March 23/2017. Have been back to see the surgeon 3 times since the operation. He said the pain could last for a year or may never resolve. At this point I have lost all confidence in this doctor as he had no empathy for my pain and suffering and how it impacted my life. . I need serious help; this problem is slowly killing me. Thank you for reading this Fred

This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A Florida jury has ordered Johnson & Johnson to pay $20 million to the family of a man who died of mesothelioma after using the company’s talc-based products for 50 years.
Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.